First Tracks Biotherapeutics closes private placement of 6,106,870 shares
First Tracks Biotherapeutics closed a private placement of 6,106,870 shares of its common stock on October 19, 2026, and entered into a registration rights agreement with the investors. The agreement requires the company to file or submit a resale registration statement with the SEC no later than 30 days after the closing date, which would allow those investors to resell the shares. The filing does not disclose the sale price or proceeds, so the financial effect on shareholders cannot be assessed from this document.
Key points
- Closing date of the private placement: October 19, 2026
- Aggregate of 6,106,870 common shares issued, par value $0.001 per share
- Registration statement for investor resale due no later than 30 days after the closing date
- Registration Rights Agreement filed as Exhibit 10.1, with some portions redacted and schedules omitted
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.